Riyaz Bashir, MD, FACC, RVT, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital, along with Nicholas Green, Director of Research & Development at Thrombolex, Inc., developed two catheters that received U.S. Food and Drug Administration premarket notification clearance back in May. Now, the first patient has enrolled in the early feasibility and safety study investigating the Bashir Endovascular Catheter for the treatment of submassive pulmonary embolism. Cardiac Interventions Today and Venous News provided additional coverage of the announcement.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH